Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Postoperative radiotherapy to the neck for pN1 status HNSCC patients after neck dissection.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • معلومة اضافية
    • المصدر:
      Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: London : Nature Publishing Group, copyright 2011-
    • الموضوع:
    • نبذة مختصرة :
      The significance of postoperative radiotherapy (PORT) to the neck for pN1 status head and neck squamous cell carcinomas (HNSCC) after neck dissection is unclear. A total of 208 patients with pN1 status HNSCC treated from January 1, 2001, to December 31, 2014, were enrolled in the current study. The 5-year regional recurrence-free survival (RRFS), overall survival (OS) and distant metastasis-free survival (DMFS) were compared between patients with or without PORT to the dissected neck. Moreover, the stratified Cox proportional hazards models were used to assess the association between PORT to the neck and survival before and after propensity score matching. Seventy-nine patients received PORT to the neck, while 129 did not. All patients were followed for over 5 years, with a median follow-up duration of 64.6 months. The PORT group did not show better survival results than the group without PORT to the neck in RRFS, OS or DMFS. Moreover, no evidence showed that PORT to the neck was independently associated with 5-year survival. PORT to the neck for pN1 status HNSCC after neck dissection did not lead to better survival. However, it is necessary to conduct prospective randomized clinical trials to confirm these results.
      (© 2022. The Author(s).)
    • References:
      Cancer. 2011 Jul 1;117(13):2917-25. (PMID: 21246523)
      Head Neck. 2014 Jan;36(1):144-51. (PMID: 23471843)
      Lancet Oncol. 2010 Jan;11(1):66-74. (PMID: 19875337)
      N Engl J Med. 2020 Jan 2;382(1):60-72. (PMID: 31893516)
      Head Neck. 2001 Jul;23(7):525-30. (PMID: 11400239)
      Nat Rev Cancer. 2011 Jan;11(1):9-22. (PMID: 21160525)
      J Clin Oncol. 2019 Jul 10;37(20):1753-1774. (PMID: 30811281)
      Oral Oncol. 2009 Apr-May;45(4-5):301-8. (PMID: 19249237)
      J Clin Oncol. 2017 Nov 1;35(31):3601-3609. (PMID: 28880746)
      Ann Surg Oncol. 2014 Sep;21(9):3049-55. (PMID: 24728823)
      Eur Arch Otorhinolaryngol. 2009 Mar;266(3):437-43. (PMID: 18648835)
      J Clin Oncol. 2015 Oct 10;33(29):3269-76. (PMID: 26351335)
      CA Cancer J Clin. 2018 Nov;68(6):394-424. (PMID: 30207593)
      Cancer. 1990 Jul 1;66(1):109-13. (PMID: 2354399)
      Am J Epidemiol. 2013 Sep 1;178(5):679-90. (PMID: 23817919)
      Head Neck. 2010 May;32(5):555-61. (PMID: 19691114)
      Ann Oncol. 2012 Sep;23 Suppl 10:x173-7. (PMID: 22987957)
      Lancet. 2008 May 17;371(9625):1695-709. (PMID: 18486742)
      Am J Surg. 1994 Nov;168(5):494-8. (PMID: 7977983)
      Head Neck. 2012 Jan;34(1):113-9. (PMID: 22162247)
      JAMA Otolaryngol Head Neck Surg. 2015 Dec;141(12):1118-27. (PMID: 25902372)
    • الموضوع:
      Date Created: 20220811 Date Completed: 20220815 Latest Revision: 20221020
    • الموضوع:
      20250114
    • الرقم المعرف:
      PMC9372140
    • الرقم المعرف:
      10.1038/s41598-022-17932-3
    • الرقم المعرف:
      35953555